Free Trial

Aurora Cannabis (ACB) Competitors

Aurora Cannabis logo
C$6.20 +0.12 (+1.97%)
As of 04:00 PM Eastern

ACB vs. THCX, CRON, GUD, TLRY, WEED, FIRE, EPI, OGI, CPH, and ICC

Should you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Hydropothecary (THCX), Cronos Group (CRON), Knight Therapeutics (GUD), Tilray Brands (TLRY), Canopy Growth (WEED), Supreme Cannabis (FIRE), ESSA Pharma (EPI), Organigram (OGI), Cipher Pharmaceuticals (CPH), and ICC Labs (ICC). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Aurora Cannabis vs. Its Competitors

Aurora Cannabis (TSE:ACB) and Hydropothecary (CVE:THCX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.

Hydropothecary has lower revenue, but higher earnings than Aurora Cannabis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora CannabisC$195.83M1.73-C$44.16M-C$0.81-7.66
HydropothecaryN/AN/AN/AN/AN/A

Aurora Cannabis presently has a consensus price target of C$8.75, suggesting a potential upside of 41.13%. Given Aurora Cannabis' stronger consensus rating and higher possible upside, analysts clearly believe Aurora Cannabis is more favorable than Hydropothecary.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
4.00
Hydropothecary
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Aurora Cannabis' average media sentiment score of 0.00 equaled Hydropothecary'saverage media sentiment score.

Company Overall Sentiment
Aurora Cannabis Neutral
Hydropothecary Neutral

13.4% of Aurora Cannabis shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Hydropothecary has a net margin of 0.00% compared to Aurora Cannabis' net margin of -22.55%. Hydropothecary's return on equity of 0.00% beat Aurora Cannabis' return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-22.55% -8.36% -1.87%
Hydropothecary N/A N/A N/A

Summary

Aurora Cannabis beats Hydropothecary on 5 of the 8 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACB vs. The Competition

MetricAurora CannabisDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$339.19MC$2.13BC$5.49BC$6.19B
Dividend YieldN/A2.92%5.39%6.72%
P/E Ratio-7.664.1427.4352.72
Price / Sales1.73545.50398.251,193.25
Price / Cash1.2510.3536.1383.29
Price / Book0.5612.548.084.76
Net Income-C$44.16MC$21.15BC$3.16BC$301.20M
7 Day Performance7.08%2.90%2.12%1.64%
1 Month Performance-15.65%5.61%4.43%4.55%
1 Year Performance-7.74%3.18%35.62%26.23%

Aurora Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACB
Aurora Cannabis
0.9925 of 5 stars
C$6.20
+2.0%
C$8.75
+41.1%
-1.6%C$339.19MC$195.83M-7.661,073
THCX
Hydropothecary
N/AC$5.30
+6.6%
N/A+0.0%C$949.11MN/A0.00N/AHigh Trading Volume
CRON
Cronos Group
N/AC$2.61
+0.4%
N/A-11.9%C$689.21MC$76.86M-14.52450News Coverage
GUD
Knight Therapeutics
N/AC$5.83
+1.4%
C$7.15
+22.6%
+4.9%C$589.71MC$348.70M-19.46725
TLRY
Tilray Brands
N/AC$0.56
+3.7%
N/A-70.5%C$360.85MC$610.34M-1.352,650
WEED
Canopy Growth
0.5803 of 5 stars
C$1.68
-0.6%
C$2.20
+31.0%
-81.0%C$270.26MC$519.68M-0.252,700
FIRE
Supreme Cannabis
N/AN/AN/AN/AC$259.40MC$53.29M-10.97400
EPI
ESSA Pharma
N/AC$8.20
+7.2%
N/A+0.0%C$237.87MN/A-8.2725
OGI
Organigram
2.6625 of 5 stars
C$1.84
flat
C$3.33
+80.7%
-7.8%C$227.32MC$180.58M-3.89987News Coverage
CPH
Cipher Pharmaceuticals
0.8967 of 5 stars
C$12.54
-1.8%
C$14.75
+17.6%
+57.8%C$225.13MC$19.03M13.855
ICC
ICC Labs
N/AC$1.62
-5.8%
N/A+0.0%C$223.64MC$533.68K95.29N/AGap Up

Related Companies and Tools


This page (TSE:ACB) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners